Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to __________

Commission File Number: 1-11398

CPI AEROSTRUCTURES, INC.

(Exact name of registrant as specified in its charter)

New York	11-2520310
(State or other jurisdiction	(IRS Employer Identification Number)
of incorporation or organization)

91 Heartland Blvd., Edgewood, NY	11717
(Address of principal executive offices)	(Zip code)

(631)586-5200

(Registrant's telephone number including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common stock, $0.001 par value per share	CVU	NYSE American

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒No ☐Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐No☒

As of May 13, 2024, the registrant had 12,856,575shares of common stock, $.001 par value, outstanding.

	INDEX
Part I - Financial Information
Item 1 - Consolidated Financial Statements (Unaudited)	3
Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023	3
Condensed Consolidated Statements of Operations for the Three Months ended March 31, 2024 and 2023 (Unaudited)	4
Condensed Consolidated Statements of Shareholders' Equity for the Three Months ended March 31, 2024 and 2023 (Unaudited)	5
Condensed Consolidated Statements of Cash Flows for the Three Months ended March 31, 2024 and 2023 (Unaudited)	6
Notes to Condensed Consolidated Financial Statements (Unaudited)	7
Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3 - Quantitative and Qualitative Disclosures About Market Risk	18
Item 4 - Controls and Procedures	19
Part II - Other Information
Item 1 - Legal Proceedings	19
Item 1A - Risk Factors	19
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3 - Defaults Upon Senior Securities	19
Item 4 - Mine Safety Disclosures	20
Item 5 - Other Information	20
Item 6 - Exhibits	20
Signatures	21

Part I - Financial Information

Item 1 - Consolidated Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

		March 31,
		2024 (Unaudited)			December 31, 2023
ASSETS
Current Assets:
Cash		$	3,018,068			$	5,094,794
Accounts receivable, net			4,982,137				4,352,196
Contract assets, net			34,016,949				35,312,068
Inventory			1,281,219				1,436,647
Refundable income taxes			40,000				40,000
Prepaid expenses and other current assets			532,458				678,026
Total Current Assets			43,870,831				46,913,731
Operating lease right-of-use assets			4,277,724				4,740,193
Property and equipment, net			741,264				794,056
Deferred tax asset			19,906,903				19,938,124
Goodwill			1,784,254				1,784,254
Other assets			174,530				189,774
Total Assets		$	70,755,506			$	74,360,132
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable		$	11,864,561			$	10,487,012
Accrued expenses			7,943,246				10,275,695
Contract liabilities			4,497,225				5,937,629
Loss reserve			133,206				337,351
Current portion of line of credit			2,160,000				2,400,000
Current portion of long-term debt			30,010				44,498
Operating lease liabilities, current			2,037,547				1,999,058
Income taxes payable			38,358				30,107
Total Current Liabilities			28,704,153				31,511,350
Line of credit, net of current portion			16,920,000				17,640,000
Long-term operating lease liabilities			2,581,128				3,100,571
Long-term debt, net of current portion			18,736				26,483
Total Liabilities			48,224,017				52,278,404
Commitments and Contingencies (see note 11)
Shareholders' Equity:
Common stock - $.001par value; authorized 50,000,000shares, 12,784,768and 12,771,434shares, respectively, issued and outstanding			12,784				12,771
Additional paid-in capital			74,154,189				73,872,679
Accumulated deficit			(51,635,484	)			(51,803,722	)
Total Shareholders' Equity			22,531,489				22,081,728
Total Liabilities and Shareholders' Equity		$	70,755,506			$	74,360,132

See Notes to Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

		For the Three Months Ended March 31,
		2024			2023
Revenue		$	19,081,143			$	22,016,668
Cost of sales			15,527,394				17,354,152
Gross profit			3,553,749				4,662,516
Selling, general and administrative expenses			2,713,904				2,869,058
Income from operations			839,845				1,793,458
Interest expense			(632,135	)			(610,896	)
Income before provision for income taxes			207,710				1,182,562
Provision for income taxes			39,472				199,257
Net income		$	168,238			$	983,305
Income per common share, basic		$	0.01			$	0.08
Income per common share, diluted		$	0.01			$	0.08
Shares used in computing income per common share:
Basic			12,486,889				12,520,299
Diluted			12,680,584				12,608,189

See Notes to Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)

		Common Stock Shares			Common Stock Amount			Additional Paid-in Capital			Accumulated Deficit			Total Shareholders' Equity
Balance at January 1, 2023			12,506,795			$	12,507			$	73,189,449			$	(69,004,926	)		$	4,197,030
Net income			-				-				-				983,305				983,305
Issuance of common stock upon settlement of restricted stock, net			19,247				19				-				-				19
Stock-based compensation expense			-				-				338,904				-				338,904
Balance at March 31, 2023			12,526,042			$	12,526			$	73,528,353			$	(68,021,621	)		$	5,519,258
Balance at January 1, 2024			12,771,434			$	12,771			$	73,872,679			$	(51,803,722	)		$	22,081,728
Net income			-				-				-				168,238				168,238
Issuance of common stock upon settlement of restricted stock, net			13,334				13				-				-				13
Stock-based compensation expense			-				-				281,510				-				281,510
Balance at March 31, 2024			12,784,768			$	12,784			$	74,154,189			$	(51,635,484	)		$	22,531,489

See Notes to Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

		For the Three Months Ended March 31,
		2024			2023
Cash flows from operating activities:
Net income		$	168,238			$	983,305
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization			99,567				116,545
Amortization of debt issuance cost			15,244				65,835
Stock-based compensation			281,523				338,923
Deferred income taxes			31,221				199,993
Bad debt expense			148,084				-
Changes in operating assets and liabilities:
Increase in accounts receivable			(778,025	)			(626,143	)
Decrease (increase) in contract assets			1,295,119				(2,978,411	)
Decrease in inventory			155,428				158,502
Decrease in prepaid expenses and other assets			145,568				6,714
Decrease in operating lease right-of-use assets			462,469				455,469
(Decrease) increase in accounts payable and accrued expenses			(867,723	)			1,217,630
(Decrease) increase in contract liabilities			(1,440,404	)			1,492,095
Decrease in lease liabilities			(480,954	)			(425,234	)
Decrease in loss reserve			(204,145	)			(112,505	)
Increase in income taxes payable			8,251				-
Net cash (used in) provided by operating activities			(960,539	)			892,718
Cash flows from investing activities:
Purchase of property and equipment			(46,775	)			(43,525	)
Net cash used in investing activities			(46,775	)			(43,525	)
Cash flows from financing activities:
Principal payments on line of credit			(960,000	)			-
Principal payments on long-term debt			(22,235	)			(644,160	)
Repayments of insurance financing obligation			(87,177	)			-
Debt issuance costs paid			-				(54,334	)
Net cash used in financing activities			(1,069,412	)			(698,494	)
Net (decrease) increase in cash			(2,076,726	)			150,699
Cash at beginning of period			5,094,794				3,847,225
Cash at end of period		$	3,018,068			$	3,997,924
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest		$	622,371			$	651,984
Income taxes		$	-			$	-

See Notes to Condensed Consolidated Financial Statements

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.	INTERIM FINANCIAL STATEMENTS

Basis of Presentation

The Company consists of CPI Aerostructures, Inc. ("CPI Aero"), Welding Metallurgy, Inc. ("WMI"), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the "Company", "we", "us", or "our").

The condensed consolidated interim financial statements of the Company as of March 31, 2024 and for the three months ended March 31, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2023 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K"). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the "CODM") to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company's CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

The Company maintains its cash in multiple financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company's balances may exceed insurance limits. As of March 31, 2024, the Company had $2,806,594of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

Recently Issued Accounting Standards - Not Adopted

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity ("PBE") to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local, and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all period presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows, and financial condition.

2.

REVENUE

Disaggregation of Revenue

The following tables present the Company's revenue disaggregated by contract type and revenue recognition method:

		Three months ended March 31,
		2024			2023
Government subcontracts		$	15,001,768			$	18,672,893
Prime government contracts			2,781,881				1,408,034
Commercial contracts			1,297,494				1,935,741
		$	19,081,143			$	22,016,668

		Three months ended March 31,
		2024			2023
Revenue recognized using over time revenue recognition model		$	18,870,366			$	20,630,230
Revenue recognized using point in time revenue recognition model			210,777				1,386,438
		$	19,081,143			$	22,016,668

Favorable/(Unfavorable) Adjustments to Gross Profit

We review our Estimates at Completion ("EAC") at least quarterly. Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenue and cost at completion is complex, subject to many inputs, and requires significant judgment by management on a contract-by-contract basis. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities, and the related changes in estimates of revenues and costs. The risks and opportunities relate to management's judgment about the ability and cost to achieve the schedule, consideration of customer-directed delays or reductions in scheduled deliveries, technical requirements, customer activity levels, and related variable consideration. Management must make assumptions and estimates regarding contract revenue and costs, including estimates of labor productivity and availability, the complexity and scope of the work to be performed, the availability and cost of materials including any impact from changing costs or inflation, the length of time to complete the performance obligation, the availability and timing of funding from our customer, and overhead cost rates, among others.

Changes in estimates of net sales, cost of sales, and the related impact to operating profit on contracts recognized over time are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods based on a performance obligation's percentage-of-completion in the current period. A significant change in one or more of these estimates could affect the profitability of one or more of our performance obligations. Our EAC adjustments also include the establishment of, and changes to, loss provisions for our contracts accounted for on a percentage-of-completion basis.

Net EAC adjustments had the following impact on our gross profit during the three months ended March 31, 2024 and 2023:

		Three months ended
		March 31, 2024			March 31, 2023
Favorable adjustments		$	912,487			$	825,981
Unfavorable adjustments			(2,085,348	)			(1,546,986	)
Net adjustments		$	(1,172,861	)		$	(721,005	)

Transaction Price Allocated to Remaining Performance Obligations

As of March 31, 2024, the aggregate amount of transaction price allocated to the remaining performance obligations was approximately $103.6million. This represents the amount of revenue the Company expects to recognize in the future on contracts with unsatisfied or partially satisfied performance obligations as of March 31, 2024.

3.	CONTRACT ASSETS AND LIABILITIES

Contract assets represent revenue recognized on contracts in excess of amounts invoiced to the customers and the Company's right to consideration is conditional on something other than the passage of time. Amounts may not exceed their net realizable value. Under the typical payment terms of our government as well as military contractor contracts, the customer retains a portion of the contract price until completion of the contract, as a measure of protection for the customer. Our government and military contractor contracts therefore typically result in revenue recognized in excess of billings, which we present as contract assets. Contract assets are classified as current assets. The Company's contract liabilities represent customer payments received or due from the customer in excess of revenue recognized. Contract liabilities are classified as current liabilities.

		March 31, 2024			December 31, 2023
Contract assets		$	34,016,949			$	35,312,068
Contract liabilities			4,497,225				5,937,629

Contract assets at March 31, 2024 decreased $1,295,119from December 31, 2023 primarily in our T-38 Pacer Classic program.

Contract liabilities decreased $1,440,404during the three months ended March 31, 2024, primarily in our Collins Aerospace Pods programs.

Revenue recognized for the three months ended March 31, 2024 and 2023 that was included in the contract liabilities balance as of January 1, 2024 and 2023, respectively, was approximately $2.0million and $1.5million, respectively.

4.

INVENTORY

The components of inventory consisted of the following:

		March 31, 2024			December 31, 2023
Raw materials		$	1,191,315			$	1,187,008
Work in progress			56,901				75,795
Finished goods			1,604,406				1,617,077
Gross inventory			2,852,622				2,879,879
Inventory reserves			(1,571,403	)			(1,443,233	)
Inventory, net		$	1,281,219			$	1,436,647

5.	STOCK-BASED COMPENSATION

In 2009, the Company adopted the Performance Equity Plan 2009 (the "2009 Plan"). The 2009 Plan reserved 500,000common shares for issuance. The 2009 Plan provides for the issuance of either incentive stock options or nonqualified stock options to employees, consultants or others who provide services to the Company. The Company has 2,364shares available for grant under the 2009 Plan as of March 31, 2024.

In 2016, the Company adopted the 2016 Long Term Incentive Plan (the "2016 Plan"). The 2016 Plan reserved 600,000common shares for issuance, provided that, no more than 200,000common shares be granted as incentive stock options. Awards may be made or granted to employees, officers, directors and consultants in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. Any shares of common stock granted in connection with awards other than stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one and one-half shares of common stock for every one share of common stock granted in connection with such award. Any shares of common stock granted in connection with stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one share for every one share of common stock issuable upon the exercise of such stock option or stock appreciation right awarded. In the fourth quarter of 2020, the Company added 800,000shares to the 2016 Plan, which increased the number of shares reserved for issuance under the 2016 Plan to 1,400,000shares. In the second quarter of 2023, the Company added an additional 800,000shares to the 2016 Plan, which increased the number of shares for reserved for issuance under the 2016 Plan to 2,200,000shares. The Company has 599,055shares available for grant under the 2016 Plan as of March 31, 2024.

Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

		Three months ended March 31,
		2024		2023
Cost of sales		$	(10,755	)		$	15,077
Selling, general and administrative			292,277				323,846
Total stock-based compensation expense		$	281,522			$	338,923

The Company grants restricted stock units ("RSUs") to its board of directors as partial compensation. These RSUs vest quarterly on a straight-line basis over a one-year period.At March 31, 2024, the weighted average remaining amortization period was nine months.

The following table summarizes activity related to outstanding RSUs for the three months ended March 31, 2024:

		RSUs			Weighted Average Grant Date Fair Value of RSUs
Non-vested - January 1, 2024			-			$	-
Granted			181,323			$	2.45
Vested			(45,328	)		$	2.45
Forfeited			-			$	-
Non-vested - March 31, 2024			135,995			$	2.45

The Company grants shares of common stock ("Restricted Stock Awards") to select employees. These shares have various vesting dates, ranging from vesting on the grant date to as late as four years from the date of grant. In the event that the employee's employment is voluntarily terminated prior to certain vesting dates, portions of the shares may be forfeited. At March 31, 2024, the weighted average remaining amortization period was 2.6years.

The following table summarizes activity related to outstanding Restricted Stock Awards for the three months ended March 31, 2024:

		Restricted Stock Awards			Weighted Average Grant Date Fair Value of Restricted Stock Awards
Non-vested - January 1, 2024			167,071			$	3.25
Granted			-			$	-
Vested			(9,294	)		$	2.93
Forfeited			(12,572	)		$	3.03
Non-vested - March 31, 2024			145,205			$	3.28

The Company grants shares of common stock ("Performance Restricted Stock Awards" or "PRSAs") to select officers as part of our long-term incentive program that will result in that number of PRSAs being paid out if the target performance metric is achieved. The award vesting is based on specific performance metrics related to accounts payable delinquency, debt, and net income during the performance period. The PRSAs vest at 0% or 100% and all three metrics must be met to vest at 100%. The PRSAs granted under this program will vest on the fourth anniversary of the grant date, subject to the aforementioned performance criteria. At March 31, 2024, the weighted average remaining amortization period was 2.5years.

The following table summarizes activity related to outstanding PRSAs for the three months ended March 31, 2024:

		PRSAs			Weighted Average Grant Date Fair Value of PRSAs
Non-vested - January 1, 2024			48,050			$	3.27
Granted			1,245			$	1.60
Vested			-			$	-
Forfeited			(6,851	)		$	3.08
Non-vested - March 31, 2024			42,444			$	3.25

The fair value of all RSUs, PRSAs and Restricted Stock Awards is based on the closing price of our common stock on the grant date. All RSUs, PRSAs, and Restricted Stock Awards vest and settle in common stock (on a one-for-one basis).

As of March 31, 2024, unamortized stock-based compensation costs related to restricted share arrangements was $463,262.

6.	NET INCOME PER SHARE

Basic and diluted income per common share is computed using the weighted average number of common shares outstanding. Diluted income per common share is adjusted for the incremental shares attributed to unvested RSUs. Incremental shares of 193,695and 87,890were used in the calculation of diluted income per common share for the three months ended March 31, 2024 and 2023, respectively.

7.	LINE OF CREDIT AND LONG-TERM DEBT

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the "Credit Agreement" or the "BankUnited Facility"). The BankUnited Facility originally provided for a revolving credit loan commitment of $30million (the "Revolving Loan") and a $10million term loan ("Term Loan"). The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the Credit Agreement.

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the "Thirteenth Amendment"). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company's existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000from January 1, 2024 through March 31, 2024, $19,080,000from April 1, 2024 through June 30, 2024, $18,360,000from July 1, 2024 through September 30, 2024, $17,640,000from October 1, 2024 through December 31, 2024, $16,920,000from January 1, 2025 through March 31, 2025, $16,200,000from April 1, 2025 through June 30, 2025 and $15,480,000thereafter, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.

The BankUnited Facility is secured by all of the Company's assets and the Revolving Loan bears interest at the Prime Rate + 3.50%. The Prime Rate was 8.50% as of March 31, 2024 and as such, the Company's interest rate on the Revolving Loan was 12.00% as of March 31, 2024.

As of March 31, 2024 and December 31, 2023, the Company had $19,080,000and $20,040,000outstanding under the Revolving Loan, respectively. $2,160,000of the Revolving Loan is payable by March 31, 2025 and the remaining balance of $16,920,000of the revolving line of credit matures and is payable by August 31, 2025.

The Company has cumulatively paid approximately $962,000of total debt issuance costs in connection with the BankUnited Facility, of which approximately $66,000and $82,000is unamortized and is included in other assets at March 31, 2024 and December 31, 2023, respectively.

Also included in long-term debt are financing leases of $48,746and $70,981at March 31, 2024 and December 31, 2023,= respectively, including a current portion of $30,010and $44,498, respectively. The maturities of the March 31, 2024 balance of these financing leases are as follows:

For the Year Ending December 31,
Remainder of 2024		$	22,263
2025			26,483
Total		$	48,746

8.	MAJOR CUSTOMERS AND VENDORS

During the three months ended March 31, 2024, our four largest customers accounted for 28%, 24%, 15%, and 11% of revenue. During the three months ended March 31, 2023, our two largest customers accounted for 36% and 28% of revenue.

At March 31, 2024, 22%, 17%, 14%, and 14% of our accounts receivable were from four of our largest customers. At December 31, 2023, 30%, 17%, 12%, and 11% of accounts receivable were due from our four largest customers.

At March 31, 2024, 27%, 20%, 18%, and 15% of our contract assets were from four of our largest customers. At December 31, 2023, 26%, 23%, 18%, and 15% of our contract assets were related to our four largest customers.

At March 31, 2024, 13% of our accounts payable was from one of our largest vendors.

9.

LEASES

The Company leases manufacturing and office space under an agreement classified as an operating lease. On November 10, 2021, the Company executed the second amendment to the lease agreement for its manufacturing and office space, which extends the lease agreement's expiration date to April 30, 2026. The lease agreement does not include any renewal options. The agreement provides for an initial monthly base amount plus annual escalations through the term of the lease. In addition to the monthly base amounts in the lease agreement, the Company is required to pay real estate taxes and operating expenses during the lease terms.

The Company also leases office equipment in agreements classified as operating leases.

For the three months ended March 31, 2024 and 2023, the Company's operating lease expense was $529,624and $546,082, respectively.

Future minimum lease payments under non-cancellable operating leases as of March 31, 2024 were as follows:

For the Year Ending December 31,
Remainder of 2024		$	1,680,674
2025			2,283,354
2026			850,276
2027			111,065
2028			9,228
Total undiscounted operating lease payments			4,934,597
Less imputed interest			(315,922	)
Present value of operating lease payments		$	4,618,675

The following table sets forth the right-of-use assets and operating lease liabilities as of:

		March 31, 2024			December 31, 2023
Assets
Right-of-use assets, net		$	4,277,724			$	4,740,193
Liabilities
Current operating lease liabilities		$	2,037,547			$	1,999,058
Long-term operating lease liabilities			2,581,128				3,100,571
Total lease liabilities		$	4,618,675			$	5,099,629

The Company's weighted average remaining lease term for its operating leases is 2.2years as of March 31, 2024. The Company's weighted average discount rate for its operating leases is 5.45% as of March 31, 2024.

10.	INCOME TAXES

Income taxes are accounted for under the asset and liability method whereby deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the consolidated financial statements carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company's policy is to record estimated interest and penalties related to uncertain tax positions in income tax expense.

The provision for income tax for the three months ended March 31, 2024 and 2023 was $39,472and $199,257, respectively. The decrease in the year-over-year provision for income tax is the result of the Company's lower year over year pre-tax book income.

The effective income tax rate for the three months ended March 31, 2024 is 19.0%. The difference between the effective income tax rate for the three months ended March 31, 2024 and the statutory income tax rate of 21.0% for the three months ended March 31, 2024 is due primarily to the estimated R&D credit, state income taxes and permanent tax differences. The effective income tax rate for the three months ended March 31, 2023 was 16.8%. The difference between the effective income tax rate for the three months ended March 31, 2023 and the statutory income tax rate of 21% for the three months ended March 31, 2023 was due to the estimated R&D credit, state income taxes and permanent tax differences.

11.	COMMITMENTS AND CONTINGENCIES

The Company may be involved in various claims, suits, assessments, investigations, and legal proceedings that arise from time to time in the ordinary course of its business. The Company accrues a liability when it is both probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company reviews these accruals at least quarterly and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period such determination is made. For some matters, the amount of liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made.

Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the Company's consolidated financial statements and notes thereto contained in this report.

Forward Looking Statements

When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the "SEC"), the words or phrases "will likely result," "management expects" or "we expect," "will continue," "is anticipated," "estimated" or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A - Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K"). We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

Business Operations

We are engaged in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in both the commercial and defense markets. We also have a strong and growing presence in the aerosystems sector of the market, with our production of various reconnaissance pod structures and fuel panel systems. Within the global aerostructure and aerosystem supply chain, we are either a Tier 1 supplier to aircraft original equipment manufacturers ("OEMs") or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the United States Department of Defense ("DOD"), primarily the United States Air Force ("USAF"). In conjunction with our assembly operations, we provide engineering, program management, supply chain management and kitting, and maintenance, repair and overhaul ("MRO") services.

Recent Developments

None.

Backlog

We produce custom assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 ("ASC 606"). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

Our total backlog as of March 31, 2024 and December 31, 2023 was as follows:

Backlog (Total)		March 31, 2024			December 31, 2023
Funded		$	103,597,000			$	118,218,000
Unfunded			406,771,000				395,133,000
Total		$	510,368,000			$	513,351,000

Approximately 96% of the total amount of our backlog at March 31, 2024 was attributable to government and military contractor contracts. Our backlog attributable to government contracts at March 31, 2024 and December 31, 2023 was as follows:

Backlog (Government)		March 31, 2024			December 31, 2023
Funded		$	99,242,000			$	115,681,000
Unfunded			390,571,000				383,574,000
Total		$	489,813,000			$	499,255,000

Our backlog attributable to commercial contracts at March 31, 2024 and December 31, 2023 was as follows:

Backlog (Commercial)		March 31, 2024			December 31, 2023
Funded		$	4,355,000			$	2,537,000
Unfunded			16,200,000				11,559,000
Total		$	20,555,000			$	14,096,000

The total backlog at March 31, 2024 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer ("NGJ") - Mid Band Pods and Advanced Tactical Pods), Collins Aerospace (Airborne Reconnaissance Pods), USAF (T-38 Classic Structural Modification Kits), Lockheed Martin (F-16 RI/DCC's), Raytheon (B-52 Radar Racks), Embraer (Phenom 300 Engine Inlets), Sikorsky (CH-53K Welded Tubes), Sikorsky (UH-60 BLACKHAWK Gunner Windows), Boeing (A-10 Main Landing Gear Pods) and Sikorsky (UH-60 BLACKHAWK Stabilator MRO).

The funded backlog at March 31, 2024 is primarily from purchase orders under long-term contracts with Raytheon (NGJ - Mid Band Pods), USAF (T-38 Classic Structural Modification Kits), Collins Aerospace (Airborne Reconnaissance Pods), Boeing (A-10 Main Landing Gear Pods), Sikorsky (CH-53K Welded Tubes), Sikorsky (UH-60 BLACKHAWK Gunner Windows), Lockheed Martin (F-16 RI/DCC's), Embraer (Phenom 300 Engine Inlets) and Raytheon (Advanced Tactical Pods).

Critical Accounting Estimates

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See Management's Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K, for a discussion of our critical accounting estimates. There have been no significant changes to the application of our critical accounting estimates during the quarter ended March 31, 2024.

Results of Operations

Revenue

Total Revenue for the three months ended March 31, 2024 was $19,081,143 compared to $22,016,668 for the same period last year, a decrease of $2,935,525 or 13.3%, driven primarily by decreases in our Raytheon NGJ - Mid Band Pods, Sikorsky UH-60 BLACKHAWK Hover Infrared Suppression System ("HIRSS") Module Assemblies and Lockheed Martin F-16 Rudder Island/Drag Chute Canisters (RI/DCC's) programs, partly offset by increases in our USAF T-38 Pacer Classic Structural Modification Kits and Collins Aerospace Pods programs.

Revenue from military subcontracts was $15,001,768 for the three months ended March 31, 2024 compared to $18,672,893 for the three months ended March 31, 2023, a decrease of $3,671,125 or 19.7%, driven primarily by decreases in our Raytheon NGJ - Mid Band Pods, Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies and Lockheed Martin F-16 RI/DCC's programs, partly offset by increases in our Collins Aerospace Pods programs.

Revenue from government military contracts was $2,781,881for the three months ended March 31, 2024 compared to $1,408,034 for the three months ended March 31, 2023, an increase of $1,373,847 or 97.6%, primarily on an increase in our USAF T-38 Pacer Classic Structural Modification Kits program.

Revenue from commercial subcontracts was $1,297,494 for the three months ended March 31, 2024 compared to $1,935,741 for the three months ended March 31, 2023, a decrease of $638,247 or 33.0%, primarily on a decrease in our Embraer Phenom Engine Inlet Assemblies program.

Cost of Sales

Total Cost of Sales for the three months ended March 31, 2024 and 2023 was $15,527,394 and $17,354,152, respectively, a decrease of $1,826,758 or 10.5%.

The components of the cost of sales were as follows:

		Three months ended
		March 31, 2024			March 31, 2023
Procurement		$	9,365,019			$	11,488,091
Labor			1,797,790				1,854,863
Factory overhead			4,267,095				3,779,878
Other cost of sales			97,490				231,320
Cost of sales		$	15,527,394			$	17,354,152

Procurement for the three months ended March 31, 2024 was $9,365,019 compared to $11,488,091 for the three months ended March 31, 2023, a decrease of $2,123,072 or 18.5%, driven primarily by decreases in our Raytheon NGJ - Mid Band Pods, Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies and Lockheed Martin F-16 RI/DCC's programs, partly offset by increases in our Collins Aerospace Pods programs.

Labor costs for the three months ended March 31, 2024 were $1,797,790 compared to $1,854,863 for the three months ended March 31, 2023, a decrease of $57,073 or 3.1%.

Factory overhead for the three months ended March 31, 2024 was $4,267,095 compared to $3,779,878 for the three months ended March 31, 2023, an increase of $487,217 or 12.9%. This increase was primarily the result of higher salary and benefit costs.

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other cost of sales for the three months ended March 31, 2024 was $97,490 compared to a $231,320 for the three months ended March 31, 2023, a decrease of $133,830 or 57.9%. The decrease is primarily the result of a higher level of loss contract reserve reduction for the for the three months ended March 31, 2024 as compared to the three months ended March 31, 2023.

Gross Profit

Gross profit and gross profit percentage ("gross margin") for the three months ended March 31, 2024 was $3,553,749 and 18.6%, respectively, compared to $4,662,516 and 21.2%, respectively, for the three months ended March 31, 2023, a decrease of $1,108,767, or 23.8%, and 260 basis points, respectively, for the reasons noted above and an unfavorable year-over-year mix.

Favorable/Unfavorable Adjustments to Gross Profit

During the three months ended March 31, 2024 and 2023, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

		Three months ended
		March 31, 2024			March 31, 2023
Favorable adjustments		$	912,487			$	825,981
Unfavorable adjustments			(2,085,348	)			(1,546,986	)
Net adjustments		$	(1,172,861	)		$	(721,005	)

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2024 were $2,713,904 compared to $2,869,058 for the three months ended March 31, 2023, a decrease of $155,154 or 5.4%. The decrease was primarily the result of lower personnel related expenses.

Interest expense

Interest expense for the three months ended March 31, 2024 was $632,135, compared to $610,896 for the three months ended March 31, 2023, an increase of $21,239 or 3.5%. The increase was the result of higher year-over-year interest rates charged on our outstanding debt under the Credit Agreement, partially offset by a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

Income Before Provision for Income Taxes

Income before provision for income taxes for the three months ended March 31, 2024 was $207,710 compared to $1,182,562 for the three months ended March 31, 2023, a decrease of $974,852 or 82.4% for the reasons noted above.

Provision for Income Taxes

Provision for income taxes for the three months ended March 31, 2024 was $39,472 compared to $199,257 for the three months ended March 31, 2023, a decrease of $159,785. The decrease in the provision for income tax is primarily the result of the Company's lower year over year pre-tax book income.

The effective income tax rate for the three months ended March 31, 2024 is 19%. The difference between the effective income tax rate for the three months ended March 31, 2024 and the statutory income tax rate of 21% for the three months ended March 31, 2024 is primarily due estimated R&D credit, state income taxes and permanent tax differences.

Net Income and Earnings per Share

Net income for the three months ended March 31, 2024 was $168,238 compared to $983,305 for the three months ended March 31, 2023, a decrease of $815,067 or 82.9% for the reasons noted above.

Basic and diluted income per share for the three months ended March 31, 2024 of $0.01 compared to $0.08 for the three months ended March 31, 2023, a decrease of $0.07, or 87.5%.

Basic and diluted income per share for the three months ended March 31, 2024 was calculated using 12,486,889 and 12,680,584 weighted average basic and diluted shares outstanding, respectively, as compared to 12,520,189 and 12,608,189 weighted average basic and diluted shares outstanding, respectively, for the three months ended March 31, 2023.

Liquidity and Capital Resources

General

At March 31, 2024, we had working capital of $15,166,678 compared to $15,402,381 at December 31, 2023, a decrease of $235,703 or 1.5%. The decrease was driven primarily by higher accounts payable, partly offset by higher accounts receivable and lower current portion of long-term debt and loss reserves.

Cash Flow

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.

Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

At March 31, 2024, we had cash of $3,018,068 compared to $5,094,794 at December 31, 2023, a decrease of $2,076,726 or 40.8%. This decrease was primarily the result of repayment of debt and cash flow used in operations.

Bank Credit Facilities

On March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the "Credit Agreement" or the "BankUnited Facility"). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the "Revolving Loan") and a $10 million term loan ("Term Loan"). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the "Thirteenth Amendment"). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company's existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 thereafter, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.

The BankUnited Facility is secured by all of the Company's assets and the Revolving Loan bears interest at the Prime Rate + 3.50%. The Prime Rate was 8.50% as of March 31, 2024 and as such, the Company's interest rate on the Revolving Loan was 12.00% as of March 31, 2024.

As of March 31, 2024 and December 31, 2023, the Company had $19,080,000 and $20,040,000 outstanding under the Revolving Loan, respectively.

There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.

Liquidity

We believe that our existing resources as of March 31, 2024 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.

Contractual Obligations

For information concerning our contractual obligations, see Contractual Obligations under Item 7 of Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2023.

Inflation

Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, the supply chain, the labor market and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company's long term contracts with its customers reflect fixed pricing and its long term contracts with its suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.

Item 3 - Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4 - Controls and Procedures

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

●	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

●	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

●	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of internal control over financial reporting for the twelve months ended December 31, 2023 based on criteria established in Internal Control- Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). In connection with this evaluation, management identified a deficiency that constituted a material weakness in our internal control over financial reporting as of December 31, 2023, pertaining to income tax accounting. For more information on this deficiency, see Item 9A. Controls and Procedures, included in our Annual Report on Form 10-K. Based on management's evaluation of internal control over financial reporting for the twelve months ended December 31, 2023, and as of March 31, 2024, our disclosure controls and procedures were not effective as of March 31, 2024 due to the aforementioned material weakness pertaining to income tax accounting.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

The Company has begun to develop new controls designed to remediate the aforementioned 2023 material weakness pertaining to income tax accounting, which the Company intends to implement during 2024.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II - Other Information

Item 1 - Legal Proceedings

Reference is made to Note 11 entitled "Commitments and Contingencies" to our unaudited condensed consolidated financial statements included in this Quarterly Report for a discussion of current legal proceedings, which discussion is incorporated herein by reference.

Item 1A - Risk Factors

"Item 1A. Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2023, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors disclosed in the Annual Report.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3 - Defaults Upon Senior Securities

None.

Item 4 - Mine Safety Disclosures

Not applicable.

Item 5 - Other Information

None.

Item 6 - Exhibits

Exhibit No.	Description
31.1*	Section 302 Certification by Chief Executive Officer and President
31.2*	Section 302 Certification by Chief Financial Officer (Principal Accounting Officer)
32.1**	Section 906 Certification by Chief Executive Officer and Chief Financial Officer
101.INS**	Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104**	Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document.

* Filed herewith

** Furnished herewith

Attached as Exhibit 101 to this report are the following formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statement of Operations for the three months ended March 31, 2024 and 2023, (ii) Condensed Consolidated Balance Sheet as of March 31, 2024 and December 31, 2023, (iii) Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2024 and 2023, (iv) Condensed Consolidated Statement of Changes in Equity for the three months ended March 31, 2024 and 2023 and (v) Notes to Condensed Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CPI AEROSTRUCTURES, INC.
Dated: May 15, 2024	By.	/s/ Dorith Hakim
		Dorith Hakim
		Chief Executive Officer and President (Principal Executive Officer)
Dated: May 15, 2024	By.	/s/ Andrew L. Davis
		Andrew L. Davis
		Chief Financial Officer (Principal Financial and Accounting Officer)

Public link

Please use the above public link if you want to share this noodl on another website.